Journals / Medicine Science / 2022 / Cilt: 11 - Sayı: 1

Hyperpigmented mycosis fungoides: A case report

Pages
416–418
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A case of mycosis fungoides is presented to increase awareness of this rare disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A sixty-six-years old male patient was evaluated in the dermatology outpatient clinic with extensive hyperpigmented macules and two tumoral lesions approximately three cm diameter around the umblicus.
📊
Key Findings & Data:However, as the complaints increased, a diagnosis of mycosis fungoides was made as a result of a skin biopsy.
💡
Conclusion & Impact:A case of mycosis fungoides is presented to increase awareness of this rare disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A sixty-six-years old male patient was evaluated in the dermatology outpatient clinic with extensive hyperpigmented macules and two tumoral lesions approximately three cm diameter around the umblicus. Antimycotic and corticosteroid treatment was administered. However, as the complaints increased, a diagnosis of mycosis fungoides was made as a result of a skin biopsy. Six cures of single- agent gemcitabine chemotherapy were administered by the hematology outpatient clinic and a complete response was obtained. A case of mycosis fungoides is presented to increase awareness of this rare disease.

🔖

Cite This Article

KORKMAZ, S., EREN, D., KUM, A., FIRAT, E., ELMAAĞAÇ, M., TEKİN, Y. (2022). Hyperpigmented mycosis fungoides: A case report. Medicine Science, Cilt: 11 - Sayı: 1, 416–418. https://ajindex.com/articles/579731

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Lauren C Pinter-Brown, Emmanuel C Besa. Cutaneus T-Cell Lymphoma. WebMD. 2011;3:236-9
  2. Hoppe RT, Wood GS, Abel EA. Mycosis Fungoides and Sezary Syndrome: Pathology, staging, and treatment. Curr Probl Cancer. 1990;1:293-5
  3. Sanjay Vinjamaram, Emmanuel C Besa. Lymphoma Non-Hodgins. WebMD 2011; 2:1-4.3
  4. Joseph M. Connors, Erick D, Francine M. Foss. Lymphoma of the Skin. Am Society Hematology. 2012;1:263-78
  5. Elder D, Elenitsas R, Jaworsky C, et al. Lever's histopathology of the skin. New York. Lippincott raven Press. 1996
  6. Zain T, Grinkemeyer MD. Mycosis fungoides: Cutaneous T eel/ Am f'am Physician. 1991;43:1703-7
  7. Kirsch IR, Watanabe R, O'Malley JT, et al. TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL. Sci Transl Med. 2015;7:308158
  8. Pimpinelli N, Olsen EA, Santucci M, et al. Defining early mycosis fungoides. J Am Acad Dermatol. 2005;53:1053-63
  9. Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110:1713-22
  10. Olsen EA, Whittaker S, Kim YH, et al. Clinical end points and response criteria in mycosis fungoides and Sezary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2011;29:2598-607
  11. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-85
  12. Ahn CS, ALSayyah A, Sangueza OP. Mycosis fungoides: an updated review of clinicopathologic variants. Am J Dermatopathol. 2014;36:933-48
  13. Agar NS, Wedgeworth E, Crichton S, et al. Survival outcomes and prognostic factors in mycosis fungoides/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010;28:4730-9
  14. Olsen EA, Rook AH, Zic J, et al. Sezary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lym phoma Consortium (USCLC). J A Acad Dermatol. 2011;64:352-404
  15. Kim EJ, Hess S, Richardson SK, e